Prevalence and Prognosis of Mild Anemia in Non-Dialysis Chronic Kidney Disease: A Prospective Cohort Study in Outpatient Renal Clinics

被引：29

作者：

De Nicola, Luca ^{[1
,2
,7
]}

Minutolo, Roberto ^{[2
,7
]}

Chiodini, Paolo ^{[2
]}

Zamboli, Pasquale ^{[2
,7
]}

Cianciaruso, Bruno ^{[3
]}

Nappi, Felice ^{[4
,10
]}

Signoriello, Simona ^{[2
]}

Conte, Giuseppe ^{[2
,7
]}

Zoccali, Carmine ^{[5
,6
,28
]}

Iodice, F. C. ^{[7
]}

Borrelli, S. ^{[7
]}

Scigliano, R. ^{[7
]}

Gallo, C. ^{[7
]}

Materiale, T. ^{[8
]}

Minale, B. ^{[8
]}

Paglionico, C. ^{[8
]}

Pota, A. ^{[9
]}

Andreucci, V. E. ^{[9
]}

Avella, F. ^{[10
]}

Di Iorio, B. R. ^{[11
]}

Bellizzi, V. ^{[11
]}

Cestaro, R. ^{[12
]}

Martignetti, V. ^{[13
]}

Morrone, L. ^{[13
]}

Lupo, A. ^{[14
]}

Abaterusso, C. ^{[14
]}

Donadio, C. ^{[15
]}

Bonomini, M. ^{[16
]}

Sirolli, V. ^{[16
]}

Casino, F. ^{[17
]}

Lopez, T. ^{[17
]}

Detomaso, F. ^{[18
]}

Giannattasio, M. ^{[18
]}

Virgilio, M. ^{[19
]}

Tarantino, G. ^{[19
]}

Cristofano, C.

Tuccillo, S. ^{[20
]}

Chimienti, S. ^{[20
]}

Petrarulo, F. ^{[21
]}

Giancaspro, V. ^{[21
]}

Strippoli, M. ^{[22
]}

Laraia, E. ^{[23
]}

Gallucci, M. ^{[24
]}

Gigante, B. ^{[24
]}

Lodeserto, C. ^{[25
]}

Santese, D. ^{[25
]}

Montanaro, A. ^{[26
]}

Giordano, R. ^{[26
]}

Caglioti, A. ^{[27
]}

Fuiano, G. ^{[27
]}

机构：

[1] Univ Naples 2, Dipartimento Gerontol, Cattedra Nefrol, IT-80131 Naples, Italy

[2] Univ Naples 2, Chair Biostat, IT-80131 Naples, Italy

[3] Univ Federico II, Div Nephrol, Naples, Italy

[4] County Hosp, Div Nephrol, Nola, Italy

[5] United Hosp, Renal Hypertens & Transplant Unit, Div Nephrol, Reggio Di Calabria, Italy

[6] CNR IBIM, Div Nephrol, Reggio Di Calabria, Italy

[7] Univ Naples 2, Med Sch, Naples, Italy

[8] Napoli ASL NA 1, Naples, Italy

[9] Univ Naples Federico II, Med Sch, Naples, Italy

[10] Nola Hosp, Nola, Italy

[11] Solofra Hosp, Solofra, Italy

[12] Sapri Hosp, Sapri, Italy

[13] Benevento Hosp, Benevento, Italy

[14] Verona Univ, Med Sch, Verona, Italy

[15] Pisa Univ, Med Sch, Pisa, Italy

[16] Chieti Univ, Med Sch, Chieti, Italy

[17] Matera Hosp, Matera, Italy

[18] Putignano Hosp, Putignano, Italy

[19] Molfetta Hosp, Molfetta, Italy

[20] Manduria Hosp, Manduria, Italy

[21] Bari Di Venere Hosp, Bari, Italy

[22] Bari Univ, Med Sch, Bari, Italy

[23] Bari S Rita Hosp, Bari, Italy

[24] Galatina Hosp, Galatina, Italy

[25] Taranto Hosp, Taranto, Italy

[26] Martina Franca Hosp, Martina Franca, Italy

[27] Catanzaro Univ, Med Sch, Catanzaro, Italy

[28] Reggio Calabria CNR, Reggio Di Calabria, Italy

[29] Messina Hosp, Messina, Italy

[30] Univ Messina, Med Sch, Messina, Italy

[31] Catania Univ, Med Sch, Catania, Italy

来源：

AMERICAN JOURNAL OF NEPHROLOGY | 2010年 / 32卷 / 06期

关键词：

Anemia; Hemoglobin; Chronic kidney disease; End-stage renal disease; Survival; 3RD NATIONAL-HEALTH; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; ASSOCIATION; HEART; PROGRESSION; HEMOGLOBIN; MORTALITY;

D O I：

10.1159/000321468

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Background/Aims: We evaluated prevalence and prognosis of mild anemia, defined as Hb (g/dl) 11-13.5 in males and 11-12 in females, in a prospective cohort of stage 3-5 chronic kidney disease (CKD) patients. Methods: We enrolled 668 consecutive patients in 25 renal clinics during 2003. Patients with frank anemia (Hb <11 or erythropoiesis-stimulating agents) at enrolment were excluded. Mild anemia was evaluated at two visits planned with an interval of 18 +/- 6 months to identify four categories: no anemia at both visits, mild anemia at visit 1 resolving at visit 2 (RES), mild anemia persisting at both visits (PER), and progression from no anemia or mild anemia at visit 1 to mild or frank anemia at visit 2 (PRO). Results: Mild anemia was present in 41.3% at visit 1 and 34.1% at visit 2. We identified PER in 22% patients, RES in 10%, and PRO in 26%. In the subsequent 40 months, 125 patients developed end-stage renal disease (ESRD) and 94 died. At competing risk model, PER predicted ESRD (hazard ratio, HR, 1.82, 95% confidence interval, Cl, 1.01-3.29) while PRO predicted both ESRD (HR 1.81, 95% Cl 1.02-3.23) and death (HR 1.87,95% CI1.04-3.37). Conclusion: In non-dialysis chronic kidney disease, mild anemia is prevalent and it is a marker of risk excess when persistent or progressive over time. Copyright (C) 2010 S. Karger AG, Basel

引用

页码：533 / 540

页数：8

共 25 条

[1] Hematocrit and left ventricular mass: The Framingham Heart Study
Amin, MG
Tighiouart, H
Weiner, DE
Stark, PC
Griffith, JL
MacLeod, B
Salem, DN
Sarnak, MJ
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (07) : 1276 - 1282
[2] [Anonymous], 2011, The statistical analysis of failure time data
[3] Kidney function and anemia as risk factors for coronary heart disease and mortality: The Atherosclerosis Risk in Communities (ARIC) Study
Astor, BC
Coresh, J
Heiss, G
Pettitt, D
Sarnak, MJ
[J]. AMERICAN HEART JOURNAL, 2006, 151 (02) : 492 - 500
[4] Association of kidney function with anemia - The Third National Health and Nutrition Examination Survey (1988-1994)
Astor, BC
Muntner, P
Levin, A
Eustace, JA
Coresh, J
[J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (12) : 1401 - 1408
[5] Hemoglobin Variability in Nondialysis Chronic Kidney Disease: Examining the Association with Mortality
Boudville, Neil C.
Djurdjev, Ognjenka
Macdougall, Iain C.
de Francisco, Angel L. M.
Deray, Gilbert
Besarab, Anatole
Stevens, Paul E.
Walker, Rowan G.
Urena, Pablo
Inigo, Pablo
Minutolo, Roberto
Haviv, Yosef S.
Yeates, Karen
Agueera, Marisa L.
MacRae, Jennifer M.
Levin, Adeera
[J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (07): : 1176 - 1182
[6] Impact of anemia on hospitalization and mortality in older adults
Culleton, Bruce F.
Manns, Braden J.
Zhang, Jianguo
Tonelli, Marcello
Klarenbach, Scott
Hemmelgarn, Brenda R.
[J]. BLOOD, 2006, 107 (10) : 3841 - 3846
[7] Global approach to cardiovascular risk in chronic kidney disease: Reality and opportunities for intervention
De Nicola, L
Minutolo, R
Chiodini, P
Zoccali, C
Castellino, P
Donadio, C
Strippoli, M
Casino, F
Giannattasio, M
Petrarulo, F
Virgilio, M
Laraia, E
Di Iorio, B
Savica, V
Conte, G
Zamboli, P
Catapano, F
Maione, E
Tirino, G
Venditti, G
Avino, D
Borrelli, S
Scigliano, R
Materiale, T
Signoriello, G
Gallo, C
Cianciaruso, B
Torraca, S
Pota, A
Andreucci, VE
Nappi, F
Avella, F
Di Iorio, BR
Bellizzi, V
D'Apice, L
Mangiacapra, S
Caserta, D
Cestaro, R
Marzano, L
Giannattasio, P
Martignetti, V
Morrone, L
Budetta, F
Gigliotti, G
Iodice, C
Rubino, R
Lupo, A
Conte, M
Panichi, V
Bonomini, M
[J]. KIDNEY INTERNATIONAL, 2006, 69 (03) : 538 - 545
[8] Dwyer J., 1993, Nutrition and the Kidney, V2, P61
[9] In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression
Eriksen, B. O.
Ingebretsen, O. C.
[J]. KIDNEY INTERNATIONAL, 2007, 72 (10) : 1242 - 1248
[10] Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics
Fine, Leon G.
Norman, Jill T.
[J]. KIDNEY INTERNATIONAL, 2008, 74 (07) : 867 - 872

← 1 2 3 →